Skip to content

Clinical trials

Phase 2/3 Hyperlipidemias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Phase: Phase 2/3 Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20091
20103
20112
20124
20151
20162
20171
20181
20192
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto6
Chonbuk National University Hospital4
AstraZeneca1
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1
Chestnut Hill Health System1
Cortria Corporation1
Merck Sharp & Dohme LLC1
Rottapharm Spain1
Shahid Beheshti University of Medical Sciences1
Taipei City Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias21
Hypertriglyceridemia3
Dyslipidemias2
Diabetes Mellitus1
Insulin Resistance1
Metabolic Syndrome1
Overweight1
Paraplegia1
Quadriplegia1
Spinal Cord Injuries1

Trials

Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.